Compare Pfizer with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ABBOTT INDIA - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER ABBOTT INDIA PFIZER/
ABBOTT INDIA
 
P/E (TTM) x 50.1 48.6 103.1% View Chart
P/BV x 8.3 15.7 53.0% View Chart
Dividend Yield % 0.4 0.4 93.9%  

Financials

 PFIZER   ABBOTT INDIA
EQUITY SHARE DATA
    PFIZER
Mar-19
ABBOTT INDIA
Mar-19
PFIZER/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs3,8408,834 43.5%   
Low Rs2,0805,458 38.1%   
Sales per share (Unadj.) Rs455.01,731.1 26.3%  
Earnings per share (Unadj.) Rs93.8211.9 44.3%  
Cash flow per share (Unadj.) Rs109.4219.9 49.7%  
Dividends per share (Unadj.) Rs22.5065.00 34.6%  
Dividend yield (eoy) %0.80.9 83.6%  
Book value per share (Unadj.) Rs658.2945.2 69.6%  
Shares outstanding (eoy) m45.7521.25 215.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.54.1 157.6%   
Avg P/E ratio x31.633.7 93.6%  
P/CF ratio (eoy) x27.132.5 83.3%  
Price / Book Value ratio x4.57.6 59.5%  
Dividend payout %24.030.7 78.2%   
Avg Mkt Cap Rs m135,420151,848 89.2%   
No. of employees `0002.63.5 75.5%   
Total wages/salary Rs m3,2384,356 74.3%   
Avg. sales/employee Rs Th7,911.410,555.5 75.0%   
Avg. wages/employee Rs Th1,230.91,249.9 98.5%   
Avg. net profit/employee Rs Th1,630.71,292.2 126.2%   
INCOME DATA
Net Sales Rs m20,81536,786 56.6%  
Other income Rs m1,6741,133 147.8%   
Total revenues Rs m22,48937,919 59.3%   
Gross profit Rs m5,7126,047 94.5%  
Depreciation Rs m714169 421.9%   
Interest Rs m7323 324.0%   
Profit before tax Rs m6,5996,989 94.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,3092,485 92.9%   
Profit after tax Rs m4,2914,503 95.3%  
Gross profit margin %27.416.4 166.9%  
Effective tax rate %35.035.6 98.4%   
Net profit margin %20.612.2 168.4%  
BALANCE SHEET DATA
Current assets Rs m27,16727,610 98.4%   
Current liabilities Rs m8,9178,569 104.1%   
Net working cap to sales %87.751.8 169.4%  
Current ratio x3.03.2 94.6%  
Inventory Days Days6860 112.6%  
Debtors Days Days3027 109.9%  
Net fixed assets Rs m8,8621,057 838.5%   
Share capital Rs m458213 215.3%   
"Free" reserves Rs m29,65619,873 149.2%   
Net worth Rs m30,11320,086 149.9%   
Long term debt Rs m250-   
Total assets Rs m39,40029,409 134.0%  
Interest coverage x91.5311.6 29.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.51.3 42.2%   
Return on assets %11.115.4 72.0%  
Return on equity %14.222.4 63.5%  
Return on capital %22.134.9 63.4%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m428369 116.1%   
Fx outflow Rs m7864,918 16.0%   
Net fx Rs m-358-4,549 7.9%   
CASH FLOW
From Operations Rs m9784,991 19.6%  
From Investments Rs m351-2,570 -13.7%  
From Financial Activity Rs m-1,099-1,428 76.9%  
Net Cashflow Rs m231993 23.2%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 63.9 75.0 85.2%  
Indian inst/Mut Fund % 7.5 7.9 94.9%  
FIIs % 4.9 0.1 4,900.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 17.1 138.6%  
Shareholders   85,207 18,270 466.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   DR. REDDYS LAB  STERLING BIOTECH  NATCO PHARMA  SUN PHARMA  IPCA LABS  

Compare PFIZER With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 244 Points Lower, Nifty Ends Below 14,300; UltraTech Cement & HCL Tech Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY21); Net Profit Down 5.1% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (down 5.1% YoY). Sales on the other hand came in at Rs 11 bn (up 1.6% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

PFIZER Announces Quarterly Results (3QFY21); Net Profit Up 1.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY21); Net Profit Down 14.8% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY21); Net Profit Up 10.3% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, PFIZER has posted a net profit of Rs 1 bn (up 10.3% YoY). Sales on the other hand came in at Rs 5 bn (down 5.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story(Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Top 3 Nifty ETFs to Buy Now(Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Apr 20, 2021 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS